載入...
Clinical outcomes of patients with giant cell arteritis treated with tocilizumab in real-world clinical practice: decreased incidence of new visual manifestations
BACKGROUND: Placebo-controlled clinical trials have demonstrated the efficacy of tocilizumab (TCZ) for remission maintenance and glucocorticoid sparing in patients with giant cell arteritis (GCA). However, limited data exist on the effectiveness and safety of TCZ for GCA in real-world clinical pract...
Na minha lista:
| 發表在: | Arthritis Res Ther |
|---|---|
| Main Authors: | , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
BioMed Central
2021
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7789742/ https://ncbi.nlm.nih.gov/pubmed/33407817 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13075-020-02377-8 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|